263 related articles for article (PubMed ID: 24013625)
1. Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor.
Vigna E; Pacchiana G; Chiriaco C; Cignetto S; Fontani L; Michieli P; Comoglio PM
J Mol Med (Berl); 2014 Jan; 92(1):65-76. PubMed ID: 24013625
[TBL] [Abstract][Full Text] [Related]
2. Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence.
Martin V; Corso S; Comoglio PM; Giordano S
Mol Oncol; 2014 Dec; 8(8):1561-74. PubMed ID: 25011627
[TBL] [Abstract][Full Text] [Related]
3. Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Kawada I; Hasina R; Arif Q; Mueller J; Smithberger E; Husain AN; Vokes EE; Salgia R
Cancer Res; 2014 Feb; 74(3):884-95. PubMed ID: 24305878
[TBL] [Abstract][Full Text] [Related]
4. Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.
Cignetto S; Modica C; Chiriaco C; Fontani L; Milla P; Michieli P; Comoglio PM; Vigna E
Mol Oncol; 2016 Jun; 10(6):938-48. PubMed ID: 27103110
[TBL] [Abstract][Full Text] [Related]
5. Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody.
Pacchiana G; Chiriaco C; Stella MC; Petronzelli F; De Santis R; Galluzzo M; Carminati P; Comoglio PM; Michieli P; Vigna E
J Biol Chem; 2010 Nov; 285(46):36149-57. PubMed ID: 20833723
[TBL] [Abstract][Full Text] [Related]
6. hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
Martinelli I; Modica C; Chiriaco C; Basilico C; Hughes JM; Corso S; Giordano S; Comoglio PM; Vigna E
J Exp Clin Cancer Res; 2022 Mar; 41(1):112. PubMed ID: 35351166
[TBL] [Abstract][Full Text] [Related]
7. Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.
Merchant M; Ma X; Maun HR; Zheng Z; Peng J; Romero M; Huang A; Yang NY; Nishimura M; Greve J; Santell L; Zhang YW; Su Y; Kaufman DW; Billeci KL; Mai E; Moffat B; Lim A; Duenas ET; Phillips HS; Xiang H; Young JC; Vande Woude GF; Dennis MS; Reilly DE; Schwall RH; Starovasnik MA; Lazarus RA; Yansura DG
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):E2987-96. PubMed ID: 23882082
[TBL] [Abstract][Full Text] [Related]
8. Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation.
Baltschukat S; Engstler BS; Huang A; Hao HX; Tam A; Wang HQ; Liang J; DiMare MT; Bhang HC; Wang Y; Furet P; Sellers WR; Hofmann F; Schoepfer J; Tiedt R
Clin Cancer Res; 2019 May; 25(10):3164-3175. PubMed ID: 30674502
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.
Vigna E; Chiriaco C; Cignetto S; Fontani L; Basilico C; Petronzelli F; Comoglio PM
Mol Oncol; 2015 Nov; 9(9):1760-72. PubMed ID: 26119717
[TBL] [Abstract][Full Text] [Related]
10. Targeting the tumor and its microenvironment by a dual-function decoy Met receptor.
Michieli P; Mazzone M; Basilico C; Cavassa S; Sottile A; Naldini L; Comoglio PM
Cancer Cell; 2004 Jul; 6(1):61-73. PubMed ID: 15261142
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
Hoyos V; Del Bufalo F; Yagyu S; Ando M; Dotti G; Suzuki M; Bouchier-Hayes L; Alemany R; Brenner MK
Mol Ther; 2015 Sep; 23(9):1497-506. PubMed ID: 26084970
[TBL] [Abstract][Full Text] [Related]
12. "Active" cancer immunotherapy by anti-Met antibody gene transfer.
Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM
Cancer Res; 2008 Nov; 68(22):9176-83. PubMed ID: 19010889
[TBL] [Abstract][Full Text] [Related]
13. A receptor-antibody hybrid hampering MET-driven metastatic spread.
Modica C; Basilico C; Chiriaco C; Borrelli N; Comoglio PM; Vigna E
J Exp Clin Cancer Res; 2021 Jan; 40(1):32. PubMed ID: 33446252
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
[TBL] [Abstract][Full Text] [Related]
15. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091
[TBL] [Abstract][Full Text] [Related]
16. Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-"decoy" strategy.
Basilico C; Modica C; Maione F; Vigna E; Comoglio PM
Int J Cancer; 2018 Oct; 143(7):1774-1785. PubMed ID: 29693242
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models.
Ai J; Chen Y; Peng X; Ji Y; Xi Y; Shen Y; Yang X; Su Y; Sun Y; Gao Y; Ma Y; Xiong B; Shen J; Ding J; Geng M
Mol Cancer Ther; 2018 Apr; 17(4):751-762. PubMed ID: 29237805
[TBL] [Abstract][Full Text] [Related]
18. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
[TBL] [Abstract][Full Text] [Related]
19. Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Tan YC; Mirzapoiazova T; Won BM; Zhu L; Srivastava MK; Vokes EE; Husain AN; Batra SK; Sharma S; Salgia R
Sci Rep; 2017 Aug; 7(1):9192. PubMed ID: 28835699
[TBL] [Abstract][Full Text] [Related]
20. Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by
Iommelli F; De Rosa V; Terlizzi C; Monti M; Panico M; Fonti R; Del Vecchio S
Clin Cancer Res; 2018 Jul; 24(13):3126-3136. PubMed ID: 29618618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
